Catalyst halts enrollment into phase II trial of CPP-109 for methamphetamine addiction March 6, 2009 No Comments
Aeolus initiates studies of AEOL-10150 as a countermeasure to mustard gas exposure Feb. 11, 2009 No Comments
DOR BioPharma forms medical advisory board to advise on development of DOR-201 Jan. 28, 2009 No Comments
Onconova successfully completes first dose cohort of phase I clinical trial of Ex-RAD Jan. 27, 2009 No Comments
Cleveland completes dosing of fourth cohort in safety study of Protectan CBLB-502 for ARS Jan. 21, 2009 No Comments
Nabi reaches agreement with FDA on SPA for a phase III clinical trial of NicVax Jan. 5, 2009 No Comments
Lundbeck initiates phase III clinical trials with nalmefene for alcohol dependence Dec. 17, 2008 No Comments
RSS